Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Impact of Epstein-Barr Virus Nuclear Antigen 1 on Neuroinflammation in PARK2 Knockout Mice with Mitochondrial Dysfunction

Version 1 : Received: 24 August 2024 / Approved: 24 August 2024 / Online: 26 August 2024 (06:58:15 CEST)

How to cite: Cossu, D.; Tomizawa, Y.; Noda, S.; Momotani, E.; Sakanishi, T.; Okada, H.; Yokoyama, K.; Sechi, L. A.; Hattori, N. Impact of Epstein-Barr Virus Nuclear Antigen 1 on Neuroinflammation in PARK2 Knockout Mice with Mitochondrial Dysfunction. Preprints 2024, 2024081776. https://doi.org/10.20944/preprints202408.1776.v1 Cossu, D.; Tomizawa, Y.; Noda, S.; Momotani, E.; Sakanishi, T.; Okada, H.; Yokoyama, K.; Sechi, L. A.; Hattori, N. Impact of Epstein-Barr Virus Nuclear Antigen 1 on Neuroinflammation in PARK2 Knockout Mice with Mitochondrial Dysfunction. Preprints 2024, 2024081776. https://doi.org/10.20944/preprints202408.1776.v1

Abstract

Keywords: Epstein-Barr virus; PARK2 knockout mice; mitochondrial dysfunction; experimental autoimmune encephalomyelitis; neuroinflammation.

Keywords

Epstein-Barr Virus; PARK2 Knockout Mice: Mitochondrial Dysfunction 

Subject

Medicine and Pharmacology, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.